{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:34:19Z","timestamp":1792683259293,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RTI2018-098830-B-I00"],"award-info":[{"award-number":["RTI2018-098830-B-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI17\/00828"],"award-info":[{"award-number":["PI17\/00828"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud y Familias, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["RD16\/0011\/0016"],"award-info":[{"award-number":["RD16\/0011\/0016"]}],"id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["ED431C 2018\/10"],"award-info":[{"award-number":["ED431C 2018\/10"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","award":["ED431G\/05"],"award-info":[{"award-number":["ED431G\/05"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bbi.2019.12.011","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T22:30:11Z","timestamp":1576708211000},"page":"256-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra"],"prefix":"10.1016","volume":"87","author":[{"given":"Ana I.","family":"Rodriguez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garrido-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Garcia-Garrote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L.","family":"Labandeira-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.12.011_b0005","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1 receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2019.12.011_b0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2019.12.011_b0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/acel.12538","article-title":"Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease","volume":"16","author":"Ansari","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbi.2019.12.011_b0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","article-title":"Disruption of the Ang II type 1 receptor promotes longevity in mice","volume":"119","author":"Benigni","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2019.12.011_b0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11357-012-9408-8","article-title":"Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity","volume":"35","author":"Benigni","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.bbi.2019.12.011_b0035","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbi.2019.12.011_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/glia.22595","article-title":"Microglial TNF-alpha mediates enhancement of dopaminergic degeneration by brain angiotensin","volume":"62","author":"Borrajo","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2019.12.011_b0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.1996.tb15418.x","article-title":"Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo","volume":"118","author":"Brown","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.12.011_b0050","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.celrep.2013.01.005","article-title":"SIRT3 reverses aging-associated degeneration","volume":"3","author":"Brown","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2019.12.011_b0055","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/HYPERTENSIONAHA.111.00241","article-title":"The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure","volume":"61","author":"Carey","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.bbi.2019.12.011_b0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-009-0725-4","article-title":"Angiotensin receptors as determinants of life span","volume":"459","author":"Cassis","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbi.2019.12.011_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jnc.14702","article-title":"Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors","volume":"150","author":"Chen","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2019.12.011_b0065","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","article-title":"Paracrine and intracrine angiotensin 1\u20137\/Mas receptor axis in the substantia nigra of rodents, monkeys, and humans","volume":"55","author":"Costa-Besada","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2019.12.011_b0070","unstructured":"Chen, Y.H., Hoffer, B. J., Olson, L., 2019b. Forced, but not spontaneous behaviors are initially upheld as dopamine transmission declines in Parkinson model. In: Society for Neuroscience Annual Meeting. Chicago, Oct. 19\u201323, 2019."},{"key":"10.1016\/j.bbi.2019.12.011_b0085","doi-asserted-by":"crossref","first-page":"26675","DOI":"10.18632\/oncotarget.5596","article-title":"Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration","volume":"6","author":"Diaz-Ruiz","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbi.2019.12.011_b0090","article-title":"Aging-related overactivity of the angiotensin\/AT1 axis decreases sirtuin 3 levels in the substantia Nigra, which induces vulnerability to oxidative stress and neurodegeneration","author":"Diaz-Ruiz","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbi.2019.12.011_b0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbi.2017.02.013","article-title":"Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures","volume":"62","author":"Dominguez-Meijide","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.12.011_b0100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/HYPERTENSIONAHA.106.070565","article-title":"Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms","volume":"49","author":"Elton","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.bbi.2019.12.011_b0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ncpneph0301","article-title":"Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity","volume":"2","author":"Felder","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.bbi.2019.12.011_b0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.bbi.2019.12.011_b0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00418-017-1585-1","article-title":"Laser capture microdissection protocol for gene expression analysis in the brain","volume":"148","author":"Garrido-Gil","year":"2017","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.bbi.2019.12.011_b0120","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","article-title":"Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models","volume":"55","author":"Garrido-Gil","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2019.12.011_b0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bbi.2019.12.011_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MNH.0b013e32831a9e0b","article-title":"Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance","volume":"18","author":"Gildea","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbi.2019.12.011_b0135","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/HYPERTENSIONAHA.119.12705","article-title":"The dopamine D1 receptor and angiotensin II Type-2 receptor are required for inhibition of sodium transport through a protein phosphatase 2A pathway","volume":"73","author":"Gildea","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.bbi.2019.12.011_b0140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/002215549904700409","article-title":"Characterization of a specific antibody to the rat angiotensin II AT1 receptor","volume":"47","author":"Giles","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbi.2019.12.011_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-2-1","article-title":"Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra","volume":"2","author":"Grammatopoulos","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbi.2019.12.011_b0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbi.2019.12.011_b0155","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/377744a0","article-title":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice","volume":"377","author":"Hein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2019.12.011_b0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCRESAHA.107.158626","article-title":"Angiotensin II-mediated oxidativeDNAdamage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways","volume":"102","author":"Herbert","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbi.2019.12.011_b0165","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.01270.2005","article-title":"Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke","volume":"291","author":"Hong","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbi.2019.12.011_b0170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/377748a0","article-title":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor","volume":"377","author":"Ichiki","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2019.12.011_b0175","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbadis.2010.02.004","article-title":"Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation","volume":"1802","author":"Jose","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbi.2019.12.011_b0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fnagi.2017.00365","article-title":"Insulin-Like Growth Factor-1 and Neuroinflammation","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbi.2019.12.011_b0185","first-page":"67","article-title":"Brain renin-angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garc\u00eda","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bbi.2019.12.011_b0190","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.25614","article-title":"Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease","volume":"28","author":"Labandeira-Garcia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2019.12.011_b0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yfrne.2016.09.003","article-title":"Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration","volume":"43","author":"Labandeira-Garcia","year":"2016","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.bbi.2019.12.011_b0200","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","article-title":"Role of the renin-angiotensin system in vascular inflammation","volume":"29","author":"Marchesi","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2019.12.011_b0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(93)90902-Y","article-title":"Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats","volume":"613","author":"Mendelsohn","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.12.011_b0210","doi-asserted-by":"crossref","first-page":"11440","DOI":"10.1073\/pnas.88.24.11440","article-title":"Differential distribution of AT1 and AT2 angiotensin II receptor subtypes in the rat brain during development","volume":"88","author":"Millan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.bbi.2019.12.011_b0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1460-9568.2007.06014.x","article-title":"Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation","volume":"27","author":"Miyoshi","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2019.12.011_b0220","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/gerona\/gly072","article-title":"Physical exercise improves aging-related changes in angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the substantia nigra","volume":"73","author":"Mu\u00f1oz","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bbi.2019.12.011_b0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.brainresbull.2009.08.002","article-title":"Sustained elevation of cyclic guanosine monophosphate induces apoptosis in microglia","volume":"80","author":"Nimmervoll","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbi.2019.12.011_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1043-2760(99)00205-2","article-title":"Signal transduction from the angiotensin II AT2 receptor","volume":"11","author":"Nouet","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbi.2019.12.011_b0235","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/002215540405200413","article-title":"Immunohistochemical and mRNA localization of the angiotensin II receptor subtype 2 (AT2) in follicular granulosa cells of the rat ovary","volume":"52","author":"Oberm\u00fcller","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbi.2019.12.011_b0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","article-title":"AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function","volume":"465","author":"Padia","year":"2013","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbi.2019.12.011_b0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11906-018-0845-3","article-title":"Dimerization of AT2 and mas receptors in control of blood pressure","volume":"20","author":"Patel","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.bbi.2019.12.011_b0250","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbabio.2015.05.022","article-title":"Mitochondrial dysfunction in aging: much progress but many unresolved questions","volume":"1847","author":"Payne","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.bbi.2019.12.011_b0255","doi-asserted-by":"crossref","first-page":"30049","DOI":"10.18632\/oncotarget.9174","article-title":"Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging","volume":"7","author":"Rodriguez-Perez","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbi.2019.12.011_b0260","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbi.2019.12.011_b0265","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.expneurol.2010.05.015","article-title":"Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease","volume":"224","author":"Rodriguez-Perez","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2019.12.011_b0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-0270(98)00078-8","article-title":"The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism","volume":"83","author":"Rozas","year":"1998","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbi.2019.12.011_b0275","article-title":"Renal expression of angiotensin type 2 (AT2; receptors during kidney damage","volume":"S21\u201326","author":"Ruiz-Ortega","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.bbi.2019.12.011_b0280","first-page":"2067","article-title":"Early expression of all the components of the renin-angiotensin-system in human development","volume":"149","author":"Sch\u00fctz","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2019.12.011_b0285","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardiores.2007.03.030","article-title":"Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells","volume":"75","author":"Selemidis","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbi.2019.12.011_b0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/hh0402.105898","article-title":". Sp1 transcription factor as a molecular target for nitric oxide- and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase- 1alpha expression in vascular smooth muscle cells","volume":"90","author":"Sellak","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbi.2019.12.011_b0295","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","article-title":"The AT2 receptor\u2013a matter of love and hate","volume":"26","author":"Steckelings","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.bbi.2019.12.011_b0300","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/NEN.0b013e3181fa0308","article-title":"Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death","volume":"69","author":"Valenzuela","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbi.2019.12.011_b0305","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.327","article-title":"Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbi.2019.12.011_b0310","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.439","article-title":"The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system","volume":"8","author":"Villar-Cheda","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbi.2019.12.011_b0315","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.neurobiolaging.2014.01.017","article-title":"Aging-related dysregulation of dopamine and angiotensin receptor interaction","volume":"35","author":"Villar-Cheda","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2019.12.011_b0320","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1460-9568.2010.07448.x","article-title":"Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease","volume":"32","author":"Villar-Cheda","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2019.12.011_b0325","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2008.127","article-title":"Aging and sedentarism decrease vascularization and VEGF levels in the rat substantia nigra. Implications for Parkinson's disease","volume":"29","author":"Villar-Cheda","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbi.2019.12.011_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.08.006","article-title":"Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration","volume":"33","author":"Villar-Cheda","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2019.12.011_b0335","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1038\/ncomms4479","article-title":"Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production","volume":"5","author":"Wang","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbi.2019.12.011_b0340","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1681\/ASN.2005070699","article-title":"Angiotensin II upregulates toll-like receptor 4 on mesangial cells","volume":"17","author":"Wolf","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbi.2019.12.011_b0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/01.ATV.0000046231.17365.9D","article-title":"Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator","volume":"23","author":"Yan","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbi.2019.12.011_b0355","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2019.12.011_b0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.regpep.2005.09.010","article-title":"Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells","volume":"132","author":"Zhao","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbi.2019.12.011_b0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-4781(01)00341-4","article-title":"The transcription factors Sp1 and Sp3 are required for human angiotensin II type 1 receptor gene expression in H295-R cells","volume":"1522","author":"Zhao","year":"2001","journal-title":"Biochim. Biophys. Acta, Gen. Subj."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119311286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119311286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:02:49Z","timestamp":1760169769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119311286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":70,"alternative-id":["S0889159119311286"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.12.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}